Thalidomide and thalidomide analogues in treatment of patients with inflammatory bowel disease: Meta-analysis

doi:10.13105/wjma.v5.i5.124

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11177)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

432

WORD

289

HTML

5120

Figures (1-6)

191

Tables (1-2)

178

Sum=6210

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

823

Download

1176

Sum=1999

Publishing Process of This Article

Item

Count

Browse

1193

Download

1775

Sum=2968

Oct 26, 2017 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Meta-Anal. Oct 26, 2017; 5(5): 124-131
Published online Oct 26, 2017. doi: 10.13105/wjma.v5.i5.124

Full Size Figure Download Figure

Figure 6 Adverse events: Fixed effects model forest plot of weighted pooled estimate.

Citation: Sami Ullah KR, Xiong YL, Miao YL, Ummair S, Dai W. Thalidomide and thalidomide analogues in treatment of patients with inflammatory bowel disease: Meta-analysis. World J Meta-Anal 2017; 5(5): 124-131
URL: https://www.wjgnet.com/2308-3840/full/v5/i5/124.htm
DOI: https://dx.doi.org/10.13105/wjma.v5.i5.124